Showing results (171-180 of 1,061) with videos related to
Sort By:
Pageof 107
Journal of the American College of Cardiology|February 2, 2002
Ethnic differences in coronary atherosclerosisMatthew J Budoff, Ted P Yang, Robert M Shavelle, et al.International Journal of Cardiology|August 1, 2006
Coronary calcium progression rates with a zero initial score by electron beam tomographyAmbarish Gopal, Khurram Nasir, Sandy T Liu, et al.Coronary Artery Disease|May 19, 2006
Assessment of coronary plaque morphology by contrast-enhanced computed tomographic angiography: comparison with intravascular ultrasoundMargaret Leila Rasouli, David M Shavelle, William J French, et al.European Heart Journal Supplements : Journal of the European Society of Cardiology|October 16, 2020
Mechanistic insights into cardiovascular protection for omega-3 fatty acids and their bioactive lipid metabolitesTimothy D O'Connell, Richard Preston Mason, Matthew J Budoff, et al.Journal of Cardiovascular Computed Tomography|February 18, 2010
Noninvasive quantitative evaluation of coronary artery stent patency using 64-row multidetector computed tomographyMurrad J Abdelkarim, Naser Ahmadi, Ambarish Gopal, et al.Current Atherosclerosis Reports|December 29, 2022
Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate ContinuesSamuel C R Sherratt, Peter Libby, Matthew J Budoff, et al.Pacing and Clinical Electrophysiology : PACE|June 29, 2010
Prospective randomized trial of venous cardiac computed tomographic angiography for facilitation of cardiac resynchronization therapyMarc J Girsky, Jerold S Shinbane, Naser Ahmadi, et al.Kidney International|March 19, 2010
Coronary artery calcification and mortality in diabetic patients with proteinuriaYi-Wen Chiu, Sharon G Adler, Matthew J Budoff, et al.BMC Medical Imaging|July 4, 2012
An alternative method for quantifying coronary artery calcification: the multi-ethnic study of atherosclerosis (MESA)C Jason Liang, Matthew J Budoff, Joel D Kaufman, et al.Coronary Artery Disease|April 10, 2020
Effect of semaglutide on coronary atherosclerosis progression in patients with type II diabetes: rationale and design of the semaglutide treatment on coronary progression trialSajad Hamal, Lavanya Cherukuri, Kashif Shaikh, et al.Pageof 107